FAF
RPRX icon

Första AP-fonden’s Royalty Pharma RPRX Stock Holding History

Första AP-fonden’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-71,400
Closed -$2.76M – 420
2025
Q4 		$2.76M Buy
71,400
+5,600
+9% +$214K 0.02% 499
2025
Q3 		$2.32M Buy
65,800
+7,000
+12% +$253K 0.01% 515
2025
Q2 		$2.12M Sell
58,800
-16,300
-22% -$540K 0.01% 522
2025
Q1 		$2.34M Sell
75,100
-169,100
-69% -$5.36M 0.02% 515
2024
Q4 		$6.23M Buy
244,200
+1,800
+0.7% +$47.7K 0.04% 353
2024
Q3 		$6.86M Buy
242,400
+6,500
+3% +$180K 0.05% 334
2024
Q2 		$6.22M Buy
235,900
+137,100
+139% +$3.8M 0.06% 311
2024
Q1 		$3M Buy
98,800
+29,700
+43% +$876K 0.03% 496
2023
Q4 		$1.94M Buy
+69,100
New +$1.9M 0.02% 542
2023
Q3 		– Sell
-71,900
Closed -$2.21M – 563
2023
Q2 		$2.21M Buy
+71,900
New +$2.44M 0.02% 512
2022
Q4 		– Sell
-51,500
Closed -$2.07M – 572
2022
Q3 		$2.07M Buy
+51,500
New +$2.2M 0.03% 508

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Första AP-fonden's RPRX Position: Q1 2026 in Review

Första AP-fonden sold out of Royalty Pharma (RPRX) in Q1 2026, closing a stake of 71,400 shares — an estimated $2.76M sold.

Första AP-fonden first reported a position in RPRX in Q3 2022 and held it in 11 quarters. The position peaked at $6.86M in Q3 2024. 592 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.

  • Första AP-fonden reported no remaining Royalty Pharma position as of Q1 2026 after selling out during the quarter.
  • Första AP-fonden sold 71,400 Royalty Pharma shares in Q1 2026, an estimated $2.76M.
  • Första AP-fonden first reported a position in Royalty Pharma in Q3 2022 and held it in 11 quarters.
  • Första AP-fonden's Royalty Pharma position peaked at $6.86M in Q3 2024.
  • 592 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.

Based on Första AP-fonden's 13F filing for Q1 2026.